122 related articles for article (PubMed ID: 26001155)
21. Regulation of TPD52 by antitumor microRNA-218 suppresses cancer cell migration and invasion in lung squamous cell carcinoma.
Kumamoto T; Seki N; Mataki H; Mizuno K; Kamikawaji K; Samukawa T; Koshizuka K; Goto Y; Inoue H
Int J Oncol; 2016 Nov; 49(5):1870-1880. PubMed ID: 27633630
[TBL] [Abstract][Full Text] [Related]
22. MiR-503 targets PI3K p85 and IKK-β and suppresses progression of non-small cell lung cancer.
Yang Y; Liu L; Zhang Y; Guan H; Wu J; Zhu X; Yuan J; Li M
Int J Cancer; 2014 Oct; 135(7):1531-42. PubMed ID: 24550137
[TBL] [Abstract][Full Text] [Related]
23. MicroRNA-101 exerts tumor-suppressive functions in non-small cell lung cancer through directly targeting enhancer of zeste homolog 2.
Zhang JG; Guo JF; Liu DL; Liu Q; Wang JJ
J Thorac Oncol; 2011 Apr; 6(4):671-8. PubMed ID: 21270667
[TBL] [Abstract][Full Text] [Related]
24. Changes in the Level of Methylation of a Group of microRNA Genes as a Factor in the Development and Progression of Non-Small Cell Lung Cancer.
Gubenko MS; Loginov VI; Burdennyy AM; Pronina IV; Kazubskaya TP; Pertsov SS
Bull Exp Biol Med; 2022 Dec; 174(2):254-258. PubMed ID: 36598670
[TBL] [Abstract][Full Text] [Related]
25. Underexpression of miR-486-5p but not Overexpression of miR-155 is Associated with Lung Cancer Stages.
Mohamed MA; Mohamed EI; El-Kaream SAA; Badawi MI; Darwish SH
Microrna; 2018; 7(2):120-127. PubMed ID: 29437031
[TBL] [Abstract][Full Text] [Related]
26. Independent validation test of the vote-counting strategy used to rank biomarkers from published studies.
Rikke BA; Wynes MW; Rozeboom LM; Barón AE; Hirsch FR
Biomark Med; 2015; 9(8):751-61. PubMed ID: 26223535
[TBL] [Abstract][Full Text] [Related]
27. miR-101 DNA copy loss is a prominent subtype specific event in lung cancer.
Thu KL; Chari R; Lockwood WW; Lam S; Lam WL
J Thorac Oncol; 2011 Sep; 6(9):1594-8. PubMed ID: 21849855
[TBL] [Abstract][Full Text] [Related]
28. Investigation of miR-136-5p key target genes and pathways in lung squamous cell cancer based on TCGA database and bioinformatics analysis.
Xie ZC; Li TT; Gan BL; Gao X; Gao L; Chen G; Hu XH
Pathol Res Pract; 2018 May; 214(5):644-654. PubMed ID: 29650443
[TBL] [Abstract][Full Text] [Related]
29. miR-367 promotes tumor growth by inhibiting FBXW7 in NSCLC.
Xiao G; Gao X; Sun X; Yang C; Zhang B; Sun R; Huang G; Li X; Liu J; Du N; Liu D; Liang R; Ren H; Qin S
Oncol Rep; 2017 Aug; 38(2):1190-1198. PubMed ID: 28656290
[TBL] [Abstract][Full Text] [Related]
30. Two microRNA panels to discriminate three subtypes of lung carcinoma in bronchial brushing specimens.
Huang W; Hu J; Yang DW; Fan XT; Jin Y; Hou YY; Wang JP; Yuan YF; Tan YS; Zhu XZ; Bai CX; Wu Y; Zhu HG; Lu SH
Am J Respir Crit Care Med; 2012 Dec; 186(11):1160-7. PubMed ID: 23043084
[TBL] [Abstract][Full Text] [Related]
31. Dual-strand tumor-suppressor microRNA-145 (miR-145-5p and miR-145-3p) coordinately targeted MTDH in lung squamous cell carcinoma.
Mataki H; Seki N; Mizuno K; Nohata N; Kamikawaji K; Kumamoto T; Koshizuka K; Goto Y; Inoue H
Oncotarget; 2016 Nov; 7(44):72084-72098. PubMed ID: 27765924
[TBL] [Abstract][Full Text] [Related]
32. Expression of miRNAs in non-small-cell lung carcinomas and their association with clinicopathological features.
Tafsiri E; Darbouy M; Shadmehr MB; Zagryazhskaya A; Alizadeh J; Karimipoor M
Tumour Biol; 2015 Mar; 36(3):1603-12. PubMed ID: 25384507
[TBL] [Abstract][Full Text] [Related]
33. Morphology and a limited number of immunohistochemical markers may efficiently subtype non-small-cell lung cancer.
Rossi G; Papotti M; Barbareschi M; Graziano P; Pelosi G
J Clin Oncol; 2009 Oct; 27(28):e141-2; author reply e143-4. PubMed ID: 19720885
[No Abstract] [Full Text] [Related]
34. Global analysis of chromosome 1 genes among patients with lung adenocarcinoma, squamous carcinoma, large-cell carcinoma, small-cell carcinoma, or non-cancer.
Zhang Y; Wang H; Wang J; Bao L; Wang L; Huo J; Wang X
Cancer Metastasis Rev; 2015 Jun; 34(2):249-64. PubMed ID: 25937073
[TBL] [Abstract][Full Text] [Related]
35. MiR-195 suppresses non-small cell lung cancer by targeting CHEK1.
Liu B; Qu J; Xu F; Guo Y; Wang Y; Yu H; Qian B
Oncotarget; 2015 Apr; 6(11):9445-56. PubMed ID: 25840419
[TBL] [Abstract][Full Text] [Related]
36. Investigation of relationship between precursor of miRNA-944 and its mature form in lung squamous-cell carcinoma - the diagnostic value.
Powrózek T; Mlak R; Dziedzic M; Małecka-Massalska T; Sagan D
Pathol Res Pract; 2018 Mar; 214(3):368-373. PubMed ID: 29496309
[TBL] [Abstract][Full Text] [Related]
37. Restoration of tumour suppressor hsa-miR-145 inhibits cancer cell growth in lung adenocarcinoma patients with epidermal growth factor receptor mutation.
Cho WC; Chow AS; Au JS
Eur J Cancer; 2009 Aug; 45(12):2197-206. PubMed ID: 19493678
[TBL] [Abstract][Full Text] [Related]
38. Classification of non-small cell lung carcinoma in transthoracic needle specimens using microRNA expression profiling.
Fassina A; Cappellesso R; Fassan M
Chest; 2011 Nov; 140(5):1305-1311. PubMed ID: 21622546
[TBL] [Abstract][Full Text] [Related]
39. miR-592 and miR-552 can distinguish between primary lung adenocarcinoma and colorectal cancer metastases in the lung.
Kim HK; Lim NJ; Jang SG; Lee GK
Anticancer Res; 2014 May; 34(5):2297-302. PubMed ID: 24778034
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of Tumor-Derived Exosomal miRNA as Potential Diagnostic Biomarkers for Early-Stage Non-Small Cell Lung Cancer Using Next-Generation Sequencing.
Jin X; Chen Y; Chen H; Fei S; Chen D; Cai X; Liu L; Lin B; Su H; Zhao L; Su M; Pan H; Shen L; Xie D; Xie C
Clin Cancer Res; 2017 Sep; 23(17):5311-5319. PubMed ID: 28606918
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
